a b s t r a c t Dopaminergic deficiency may affect Parkinson's disease patients (PD) in the central as well as the peripheral tissues. In the retina, the neuromodulatory role of the dopaminergic Interplexiform cell layer (IP) plays a major role in the retinal light adaptation and may account for the duration of the negative afterimage. Here we present results showing a significant reduction of negative afterimage duration in PD patients. This supports the hypothesis that the retinal dopaminergic system may be the main cause for the long duration of negative afterimage. We suggest that the observed reduction of afterimage duration is due to possible dopaminergic deficiency in patients with Parkinson's disease.
Introduction
Parkinson's disease (PD) is characterized by a general dopamine deficiency (Scatton, Jovoy-Agrid, Rouquier, Dubois, & Agid, 1993) . Although motor impairment has been the focus of the clinical evaluation and therapy of PD patients, non-motor manifestations such as cognitive impairment have also been studied (Lang & Lozano, 1998) and evidence for abnormalities of early vision in Parkinson's disease is widely reported in the literature (Armstrong, 2008; Bodis-Wollner, 1990; Bulens, Meerwaldt, Dan der Wildt, & Keemink, 1986; Crevits, 2003; Djamgoz, Hankins, Hirano, & Archer, 1997; Harnois & Di Paolo, 1990; Harris, 1998; Masson, Mestre, & Blin, 1993; McMahon, Knapp, & Dowling, 1989; Riklan, 1972; Rodnitzky, 1998; Wink & Harris, 2000) . It is suggested that the observed changes in perception as well as other non-motor manifestations of Parkinson's disease are due to varied patterns of degeneration in dopaminergic neural systems. Some anatomical studies show that dopamine in Parkinsonian retina is reduced and dopaminergic neurons appear distorted (Bodis-Wollner, 1990; Djamgoz et al., 1997; Harnois & Di Paolo, 1990; Harris, 1998; Masson et al., 1993; Rodnitzky, 1998; Wink & Harris, 2000) .
Other researches have demonstrated a substantial reduction in retinal dopamine content in MPTP-treated monkeys (Ghilardi, Bodis-Wollner, Onofrj, Marx, & Glover, 1988) . Dopamine amacrine cells are found in the retina of many species including human (Frederick, Rayborn, Laties, Lam, & Hollyfield, 1982) and the Interplexiform cells in humans and other primates which are in contact with the amacrine and horizontal cells employ dopamine as a neurotransmitter (Dowling, 1991) . Prolonged visual evoked potential latencies and abnormal electroretinographic patterns, both of which respond to levodopa therapy, have been demonstrated in Parkinson's disease patients and in primates with experimental Parkinsonism (Rodnitzky, 1998) . It is reasonable therefore to assume that disruption of dopamine cells in the retina plays a major role in changes of basic visual perception in PD patients.
Among well known studies of perceptual changes in PD patients are reduction in the ability to detect flicker (Riklan, 1972) , abnormalities in spatial contrast sensitivity function (Bulens et al., 1986) , decreased dynamic contrast sensitivity (Masson et al., 1993) , changes in the receptive field size of the horizontal cells (McMahon et al., 1989) and visual abnormalities which are similar to the changes accompany dark adaptation in normal subjects (the parkinsonian retina behaves as though inappropriately dark-adapted) (Wink & Harris, 2000) . In general, the involvement of retinal dopamine deficiency in some of the visual deficits in Parkinson's disease is strong (Djamgoz et al., 1997) . But, although many such abnormalities including cognitive deficits are reported in the literature, to our knowledge no such study has yet described change in the duration of afterimage perception. This is important with respect to the question of how dopamine deficiency may influence afterimage duration in PD patients. According to Hayhoe, Benimoff, and Hood (1987) there are three distinct processes underlying light adaptation: a fast subtractive process, a slower divisive process and a very slow subtractive process operating over several seconds (Hayhoe, Levin, & Kosel, 1992) . Among all the other retinal cells involved in early stages of visual processing it is the Interplexiform (IP) circuit which operates very slowly by neural standards with a time constant on the order of several seconds (Wilson, 1997) . One consequence of retinal light adaptation is the production of retinal afterimages which occur when adjacent patches of retina are adapted to different light intensities. In fact, experimental measurements have revealed that negative afterimage decays exponentially with a time constant of 4-8 s (Burbeck & Kelly, 1984) .
This predicts an afterimage decay time well above 7-8 s. According to one model (Wilson, 1997) , the slow time course of afterimage decay can be explained by the very slow dynamics of the IP layer. In other words the slow build-up and decay of retinal dopaminergic neuromodulation of the IP cells is assumed to be responsible for the slow decay of the negative afterimage (Wilson, 1999) . A disruption of this dopaminergic neuromodulation process therefore, should produce a corresponding change in the duration of afterimage perception. Our results show that this is indeed the case i.e., a reduction in negative afterimage duration is observed in patients with Parkinson's disease where a possible reduction of retinal dopamine is expected.
Methods

Subjects
Four patients with Parkinson's disease participated in the experiments. Patients were selected from the outpatient clinic of neurosurgery of Shahid Beheshti University of Medical Sciences. Patients' ages varied between 42 and 65.
Inclusion criterion was the ability of the patients to learn the tasks during the learning phase properly.
A neurologist consultation was obtained, who determined subjects were off drug during the test. All patients were off drug during the learning and the test phase.
Four self-declared neurologically healthy participants who had normal mini mental state examinations served as the control group for identifying the afterimage duration in the present experimental set-up.
No subject had acute, confounding medical, psychiatric or neurologic conditions. All subjects had normal or corrected to normal vision. The groups were matched for age. Subject characteristics are listed in Table 1 .
Equipments
The stimulus sequence generation and experimental control were done by MATLAB Psychophysics Toolbox (Pelli, 1997; Brainard, 1997) running on a 3 GHz Intel PC processor. Images were displayed on a 15 00 flat, CRT, RGB, LG color monitor (1024HÂ 800V pixel resolution at 75 Hz frame rate, c = 1.93).
Procedures
In the present study we measured the negative afterimage. The experiment was composed of two parts; the training phase and the test phase. Subjects were examined individually in a dark, quiet room while seated in an adjustable chair in front of a computer. The distance between monitor and subject was 53 cm.
Training phase
To make sure that the subjects were able to report the presence of a low contrast image accurately (similar to the expected afterimage in the main experiment), subjects took part in the training phase. Subjects who were successful in the training phase took part in the test phase as well. This way we made sure that performance differences in the test phase were not caused by any other cognitive disorder in the patients, hindering their sensory-motor abilities.
During the training phase subjects fixated at a red cross in the middle of a white screen. A gray circle appeared and disappeared at random intervals ( Fig. 1 ) Subjects were instructed to push the key whenever the circle showed up and release it as soon as the circle disappeared.
Test phase
In the test phase, a common procedure for observing negative afterimages was adopted as follows:
Initially a white circle on a dark background appeared for about 20 s and was replaced with a white screen with a fixation point at the middle, after the adaptation period (Fig. 2) . Subjects were asked to press the key whenever they saw the negative afterimage and to release it when no afterimage was seen.
The trial ended after 60 s and the screen turned black at the end of each trial. Inter-trail interval was about 5 s and each subject went through 20 trials.
Data analysis
To evaluate the difference in afterimage duration between the two groups (patients/controls) we used unpaired sample T-test (the significant level was defined as P < 0.05 (two-tailed)).
Results
To make sure that the subjects were accurately reporting the appearance of the gray circle during the experiment we calculated the error on reporting the duration ''error on reporting the duration" during the training phase by subtracting the onset error from the offset error.
Subjects with delays or errors on reporting the duration outside an acceptable range of about one second in training phase were excluded from the experiment.
We excluded the results of two subjects from our final analysis -these subjects showed astonishing low afterimage duration of about 1-2 s and showed good performance on their training phase, therefore they were not excluded during the test phase. The reasons are explained in the discussion.
Four PD patients were chosen for further analysis. There was no significant difference of the ''error on reporting the duration" of the stimuli in the first part between two groups (patients/controls) ( Table 2) . The negative afterimage durations were significantly shorter in patients with PD as compared with control subjects (Pvalue = 4.63EÀ03) ( Table 3 ). The same results were obtained after correcting for the error on reporting the duration (Pvalue = 4.40EÀ03).
The afterimage duration in the control group was longer than 6 s in 91% of trials (the oldest subject (C1) showed the longest afterimage duration). While for patients it was shorter than 6 s in 83% of the trials. In other words in most trials, PD patients reported afterimage durations shorter than 6 s while in the case of control subjects almost the opposite held true. Besides, in none of the off-drug cases where the patients did well on the training phase was a negative result observed (i.e., longer duration of afterimage duration). Fig. 3 shows the result in more details for both the controls and the four off-drug patients.
Discussion
The objective of the present study was to investigate the effects of dopamine deficiency in Parkinson patients on afterimage duration. Based on Wilson's model of light adaptation, both the formation and decay of afterimages in the retina can be explained by the very slow neuromodulatory role of the Interplexiform (IP) layer cells. Our prediction was that any deficiency or reduction of dopamine in IP layer will result in a corresponding reduction in the perception of afterimage duration.
Here in our experiment, results of subjects agreed well with the perception of afterimage duration (above 7-8 s) in normal population reported in literature (Burbeck & Kelly, 1984; Kelly & Martinez-Vriegas, 1993) . The results of the present study show a Fig. 1 . During this phase subjects fixated at a red cross in the middle of a white screen. A gray circle appeared and disappeared at random intervals, while subjects pressed and held the key for as long as the image remained on the screen. Subjects were instructed to release the key immediately after the disappearance of the stimulus. Fig. 2 . Initially a white circle on a dark background appeared for about 20 s after which a white screen with a fixation point at the middle was shown. Subjects were to press a key upon the appearance of the negative afterimage and to release it when no afterimage was seen. Inter-trail interval was about 5 s.
Table 2
In the training phase the error on reporting the duration was calculated by subtracting the onset from the offset error. There was no significant difference of the ''error on reporting the duration" of the stimuli in the first part between two groups (patients/ controls). significant reduction in perceiving afterimage duration in PD subjects compared to the normal control subjects as big as 2-3 s. Given that all the other cells including the retinal ganglion cells have time constants in the order of milliseconds, had it been that dopamine based processes were operating on a shorter time constant in the millisecond range the result would have been different and no reduction would be observed. Our result does not rule out other theories of afterimage perception such as bleaching of the photoreceptors or the involvement of yet higher cortical circuitries. Wilson's model, however, argues for a direct link between a perceptual experience, negative afterimage duration, and a specific neural substrate, neuromodulatory dopaminergic system in the retina. Based on the known retinal anatomy (Dowling, 1987 ) the model consists of two distinct neural pathways; a direct pathway from the cones to bipolar to retinal output ganglion cells and an indirect or adaptive pathway consisting of the amacrine to Interplexiform to horizontal cells. For our present purpose this amarcine to Interplexiform to horizontal cell circuitry acts a neuromodulatory role and uses dopamine as its neurotransmitter. The two other major circuitries; the so-called subtractive feedback circuitry of the horizontal to cone cells and the divisive feedback circuitry of the amacrine to the bipolar cells operate on the millisecond range and according to Wilson's model could not be the basis for the long duration of negative afterimage duration. The interplay of the time constants in the adaptive pathway makes it the only candidate for causing such effects in the range of several seconds. Reduction of dopamine in the retina of PD patients might result in an increase in the neuromodulatory activity of the IP cells which can shorten the time constant of the horizontal cells. Overall Wilson's model well predicts the negative afterimage formation generated by a stationary grating. The important point is that the negative afterimage is a byproduct of retinal neuromodulation by IP cells. Another important aspect of the model is that in case only the direct pathway is active as when a fast flash of light is shown or as a result of reduction of dopamine in the IP circuitry the model predicts a slowing down of the corresponding decay and formation of afterimage duration.
Two of the PD subjects showed astonishing low afterimage duration of about 1-2 s and also showed good performance on their training phase. This compiled well with the main hypothesis of the present study but we excluded the results of these subjects in the final analysis for two reasons: either the afterimage formation process was different or the subjects were almost depleted of dopamine. This of course would be a subject for further research where a larger scale study of low to high graded Parkinson patients is possible.
In one other patient where the patient was tested in both ondrug and off drug conditions the result showed a longer duration of afterimage when the usual medical treatment of levodopa had been taken around 1-2 h before the experiments. However, as it is recently reported that dopaminergic medication may improve certain types of perceptual performance and hinder others (Ashley et al., 2007) , in this case elongation of afterimage might be caused by a different perceptual mechanism. Therefore, although the longer duration of perceived afterimage in the on-drug condition is in accordance with our prediction we did not pool the results of this subject as yet no rising of dopamine level in the retina is reported following L-Dopa therapy.
A systematic differentiation of the on/off-drug cases of patients with PD must await a thorough investigation in a future research. What is important, however, is that in none of the off-drug cases where the patients did well on the training phase did we observe a negative result (i.e., longer duration of afterimage duration).
Conclusion
Our results show a significant reduction of negative afterimage duration in off-drug patients with Parkinson's disease. As we argued in the discussion section this result correlates well with a possible deficiency in the retinal dopaminergic system of the PD patients. Fig. 3 . This graph shows the result in more details for both the controls and patients. Vertical axis represents number of trails and horizontal axis represents afterimage duration in second. Each dot represents number of trials subjects reported corresponding afterimage duration. PD curve shows the results for all of the patients as a group. Control curve shows the same for normal subjects.
Although by no means conclusive the measured afterimage duration can be thought of as an indirect measure of dopamine depletion level in the retina and carries on some rather interesting predictions about the state of the PD in the general population.
It remains to be shown, for example, whether a larger scale study on patients with mild to moderate Parkinson's disease will replicate similar findings and whether afterimage duration co-varies with severity of the disease.
This result also have implications for the existing diagnostic measures in clinical practice in that a reduction in afterimage duration can signify the progressive rate of the dopaminergic disruption in patients with Parkinson's disease.
This motivates further research on population of PD patients with mild to moderate category as well as research on (on/offdrug) cases to be carried out in the near future.
